Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02960074 · ClinicalTrials.gov registry record · Phase 1
Evaluating the Safety and Efficacy of Oral Encapsulated Fecal Microbiota Transplant in Peanut Allergic Patients
A Phase 1 study, sponsored by Rima Rachid.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT02960074 is a Phase 1 study that has completed, run by Rima Rachid. The registered enrollment target is 15 participants.
The verdict
NCT02960074, a Phase 1 study, has completed, sponsored by Rima Rachid.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
This is a Phase I trial to evaluate the safety and efficacy of oral encapsulated fecal microbiota transplantation (FMT) in the treatment of peanut allergy. In this research the investigators would like to learn more about ways to treat peanut allergies. There is currently no known cure for peanut allergy. The primary aim is to assess safety and tolerability of oral FMT in patients with peanut allergy aged 18-40 years.
Interventions
- BIOLOGICAL Fecal Microbiota Capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2017-03-03 |
| Est. Completion | 2021-07-28 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02960074
The ClinicalTrials.gov registry entry for NCT02960074 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rima Rachid, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fecal Microbiota Capsule is the first listed.
NCT02960074 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02960074 about?
NCT02960074 is a clinical study titled "Evaluating the Safety and Efficacy of Oral Encapsulated Fecal Microbiota Transplant in Peanut Allergic Patients". This is a Phase I trial to evaluate the safety and efficacy of oral encapsulated fecal microbiota transplantation (FMT) in the treatment of peanut allergy. In this research the investigators would like to learn more about ways to treat peanut allergies. There is currently no known cure for peanut al...
What is the current status of trial NCT02960074?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2017-03-03. Estimated completion is 2021-07-28.
What interventions are being tested in trial NCT02960074?
The interventions under investigation include: Fecal Microbiota Capsule (BIOLOGICAL).
Who is sponsoring clinical trial NCT02960074?
This trial is sponsored by Rima Rachid, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.